AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionReston Wealth Management Llc
Latest Disclosed Ownership1,481 shares
Latest Disclosed Value $ 322,200
Reston Wealth Management Llc reports 14.74% decrease in ownership of 4AB / AbbVie Inc.

On April 13, 2026 - Reston Wealth Management Llc filed a 13F-HR form disclosing ownership of 1,481 shares of AbbVie Inc. (DE:4AB) valued at $274,577 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,737 shares of AbbVie Inc.. This represents a change in shares of -14.74% during the quarter. The current value of the position is $279,168 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F ABBVIE COM 00287Y109 1,481 -256 -14.74 322 -18.69 0.0987
2026-02-12 2025-12-31 13F ABBVIE COM 00287Y109 1,737 266 18.08 397 16.47 0.1214
2025-10-21 2025-09-30 13F ABBVIE COM 00287Y109 1,471 49 3.45 341 29.28 0.1100
2025-08-06 2025-06-30 13F ABBVIE COM 00287Y109 1,422 -151 -9.60 264 -20.06 0.0925
2025-04-24 2025-03-31 13F ABBVIE COM 00287Y109 1,573 179 12.84 330 33.20 0.1332
2025-01-23 2024-12-31 13F ABBVIE COM 00287Y109 1,394 -18 -1.27 248 -11.15 0.0921
2024-10-28 2024-09-30 13F ABBVIE COM 00287Y109 1,412 10 0.71 279 15.83 0.1010
2024-07-30 2024-06-30 13F ABBVIE COM 00287Y109 1,402 -38 -2.64 241 -8.40 0.0962
2024-05-09 2024-03-31 13F ABBVIE COM 00287Y109 1,440 -87 -5.70 262 11.02 0.1065
2024-01-24 2023-12-31 13F ABBVIE COM 00287Y109 1,527 1,527 237 0.1083
2022-11-14 2022-09-30 13F ABBVIE COM 00287Y109 0 -1,514 -100.00 0 -100.00
2022-07-28 2022-06-30 13F ABBVIE COM 00287Y109 1,514 5 0.33 232 -5.31 0.1292
2022-05-04 2022-03-31 13F ABBVIE COM 00287Y109 1,509 28 1.89 245 21.89 0.1257
2022-02-09 2021-12-31 13F ABBVIE COM 00287Y109 1,481 1,481 201 0.0975
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.